Coassociation of ERα and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence

被引：0
|
作者：
Redmond, A. M. [1 ]
Bane, F. T. [1 ]
Stafford, A. T. [1 ]
McIlroy [1 ]
Dillon, M. F. [1 ]
Hill, A. D. K. [1 ]
Young, L. S. [1 ]
机构：
[1] Royal Coll Surgeons Ireland, Dublin 2, Ireland
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：214S / 214S
页数：1
相关论文
共 23 条
  • [21] p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane
    Vanacker, Helene
    Treilleux, Isabelle
    Schiffler, Camille
    Bieche, Ivan
    Campone, Mario
    Patsouris, Anne
    Arnedos, Monica
    Cottu, Paul H.
    Jacquin, Jean-Philippe
    Dalenc, Florence
    Pinton, Antoine
    Servant, Nicolas
    Attignon, Valery
    Rouleau, Etienne
    Morel, Alain
    Legrand, Francois
    Jimenez, Marta
    Andre, Fabrice
    Bachelot, Thomas
    [J]. BRITISH JOURNAL OF CANCER, 2024, 130 (04) : 613 - 619
  • [22] Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2-Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2-Breast Cancer
    Rosswag, Sven
    Cotarelo, Cristina L.
    Pantel, Klaus
    Riethdorf, Sabine
    Sleeman, Jonathan P.
    Schmidt, Marcus
    Thaler, Sonja
    [J]. CANCERS, 2021, 13 (08)
  • [23] High nuclear p27kip1 levels predicts sensitivity to neoadjuvant letrozole in ER plus breast cancer independent of pAKT levels, PIK3CA mutation status and cell cycle effects:: a potential role for p27kip1 in predicting enhanced autophagocytosis in response to aromatase inhibitor therapy.
    Ellis, M. J.
    Tao, Y.
    Lin, L.
    Evans, D. B.
    Miller, W. R.
    Weber, J.
    DeSchryver, K.
    Crowder, R.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S187 - S187
123